SKI Market

Indian Indices

Nifty

24,500.90 -211.15
(-0.85%)

Sensex

80,080.57 -705.97
( -0.87%)

Bank Nifty

53,820.35 -630.10
( -1.16%)

Nifty IT

35,488.80 -574.40
( -1.59%)

Global Indices

Nasdaq

45,588.04 148.96
(0.33%)

Dow Jones

6,502.95 16.01
(0.25%)

Hang Seng

42,793.22 272.95
(0.64%)

Nikkei 225

9,216.82 -38.68
(-0.42%)

Forex

USD-INR

87.65 0.14
(0.16%)

EUR-INR

102.03 -0.15
(-0.14%)

GBP-INR

118.08 0.03
(0.03%)

JPY-INR

0.59 0.00
(0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

2.4715734

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

40.63

EPS(TTM)

Face Value()

Div & Yield %

Back

balaxi pharmaceuticals ltd

Credent Global Finance Ltd - Announcement under Regulation 30 (LODR)-Acquisition

Mar 19,2025

Enclosed herewith is the disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations2015-Acquisition

24,500.90 -211.15 (-0.85%)

80,080.57 -705.97 ( -0.87%)

53,820.35 -630.10 ( -1.16%)

35,488.80 -574.40 ( -1.59%)

45,588.04 148.96 (0.33%)

6,502.95 16.01 (0.25%)

42,793.22 272.95 (0.64%)

9,216.82 -38.68 (-0.42%)

87.65 0.14 (0.16%)

102.03 -0.15 (-0.14%)

118.08 0.03 (0.03%)

0.59 0.00 (0.15%)